DEC Q2 2026 Earnings Call: Cash Flow Improves but High Leverage Keeps Risk Elevated

What happened

During the Q2 2026 earnings call, management highlighted robust free cash flow generation driven by improved natural gas realizations and effective hedging, which allowed modest debt reduction and reinforced the sustainability of the mature-well business model. Cash flow strength was partially offset by continued cost inflation in lease operating expenses and plugging obligations, keeping leverage ratios elevated but trending slightly lower. The call underscored the asymmetry of the investment thesis: if gas prices remain supportive and execution on cost control and asset retirement obligations remains disciplined, equity value could re-rate meaningfully toward the large DCF-derived intrinsic value. However, the capital structure remains fragile, with net debt/EBITDA still well above mid-single digits and interest coverage barely above 1x, leaving little room for adverse commodity or regulatory shocks. Overall, the quarter provided incremental evidence that the deleveraging path is viable, but the thesis remains reliant on a favorable macro backdrop and flawless operational delivery.

Implication

Investors should closely monitor sustained free cash flow generation and debt reduction over the next several quarters; if net debt/EBITDA continues to decline and interest coverage strengthens, the stock could be upgraded to BUY. Conversely, any deterioration in gas prices, cost control, or regulatory pressures would quickly impair the thin margin of safety, so this remains a high-risk, deep-value situation suitable only for those comfortable with significant balance-sheet risk.

Thesis delta

The Q2 2026 call confirmed management's ability to generate free cash flow and pay down debt amid rising gas prices, improving the risk/reward profile. However, leverage remains elevated and the path to full deleveraging requires sustained high prices and tight cost control, so the POTENTIAL BUY judgment is unchanged. No material shift in thesis, but the quarter adds modest positive evidence to the watch list.